Plain-English translation of NCT05134454 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
After a stroke or mini-stroke, doctors often use heart monitors (ECG) to check for irregular heartbeats, especially a condition called atrial fibrillation that increases stroke risk. This trial compares two approaches: standard monitoring for 1–2 days versus extended monitoring that includes longer devices worn over weeks. Researchers want to know if catching more irregular heartbeats with extended monitoring helps prevent future strokes and saves lives.
Many stroke survivors have undetected irregular heartbeats that could be treated to prevent another stroke, but doctors aren't sure whether longer monitoring helps find these cases and actually improves outcomes. This trial will provide clear evidence to guide how hospitals should screen for these dangerous heart rhythms.
You will be randomly assigned to receive either standard heart monitoring (1–2 days of continuous recording) or extended monitoring (initial recording plus at least two separate 14-day monitoring periods with a portable device). You will have visits with the study team to place and remove monitors, and researchers will track your health outcomes over time to see which approach works better at preventing future strokes and other health events.
AI-generated summary from trial data · Aug 17, 2026 · Not medical advice
Sweden